Another Company Recalls Its Generic Zantac — What Should Heartburn Sufferers Take Instead?

Published Nov 8, 2019

NOW
PLAYING
Zantac Maker Recalls The Heartburn Drug After FDA Warning That It May Be Linked To Cancer
NOW
PLAYING
What Are The Side Effects of PARP Inhibitors?
NOW
PLAYING
The Zantac Recall--Pepcid and Tagamet Are Good Options To Avoid Cancer Risk
NOW
PLAYING
If Heartburn Drug Zantac Is Being Pulled From Stores For Cancer Link, Why Are There Still Ads For It On TV?
NOW
PLAYING
How Do PARP Inhibitors Work?
NOW
PLAYING
A Popular Heartburn Drug is Being Recalled For Its Potential Cancer Risk -- Here's What You Can Do For Your Heartburn Instead